Your browser doesn't support javascript.
loading
Health care professional barriers and facilitators to discontinuing antidepressant use: A systematic review and thematic synthesis.
Van Leeuwen, Ellen; Maund, Emma; Woods, Catherine; Bowers, Hannah; Christiaens, Thierry; Kendrick, Tony.
Afiliación
  • Van Leeuwen E; Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Ghent University, Belgium; Department of Public Health and Primary Care, Ghent University, Belgium. Electronic address: ellen.vanleeuwen@ugent.be.
  • Maund E; Primary Care Research Centre, School of Primary Care, Population Health & Medical Education, University of Southampton, Southampton, United Kingdom.
  • Woods C; Primary Care Research Centre, School of Primary Care, Population Health & Medical Education, University of Southampton, Southampton, United Kingdom.
  • Bowers H; Primary Care Research Centre, School of Primary Care, Population Health & Medical Education, University of Southampton, Southampton, United Kingdom.
  • Christiaens T; Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Ghent University, Belgium.
  • Kendrick T; Primary Care Research Centre, School of Primary Care, Population Health & Medical Education, University of Southampton, Southampton, United Kingdom.
J Affect Disord ; 356: 616-627, 2024 Jul 01.
Article en En | MEDLINE | ID: mdl-38640978
ABSTRACT

INTRODUCTION:

Long-term antidepressant (AD) use, much longer than recommended, is very common and can lead to potential harms.

OBJECTIVE:

To investigate the existing literature on perspectives of health professionals (HPs) regarding long-term AD treatment, focusing on barriers and facilitators to discontinuation.

METHODS:

A systematic review with thematic synthesis. Eight electronic databases were searched until August 2023 including MEDLINE, PubMed, Embase, PsycINFO, CINAHL, AMED, Health Management Information Consortium, and the Networked Digital Library of Theses and Dissertation.

RESULTS:

Thirteen studies were included in the review. Of these, nine focused on general practitioner perspectives, one on psychiatrist perspectives, and three on a mix of HPs perspectives. Barriers and facilitators to discontinuing long-term ADs emerged within eight themes, ordered chronologically based on HP considerations during an AD review perception of AD use, fears, HP role and responsibility, HPs' perception of AD discontinuation, HPs' confidence regarding their ability to manage discontinuation, perceived patient readiness to stop, support from patient's trusted people, and support from other HPs.

LIMITATIONS:

Coding and development of subthemes and themes was performed by one researcher and further developed through discussion within the research team.

CONCLUSION:

Deprescribing long-term ADs is a challenging concept for HPs. The review found evidence that the barriers far outweigh the facilitators with fear of relapse as a main barrier. HP education, reassurance and confidence-building is essential to increase the initiation of the discontinuation process. Further research into the perspectives of pharmacists and mental health workers is needed as well as exploring the role of trusted people.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antidepresivos Límite: Humans Idioma: En Revista: J Affect Disord Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antidepresivos Límite: Humans Idioma: En Revista: J Affect Disord Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos